230 related articles for article (PubMed ID: 26620360)
1. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection.
Zhou X; Xu L; Wang W; Watashi K; Wang Y; Sprengers D; de Ruiter PE; van der Laan LJ; Metselaar HJ; Kamar N; Peppelenbosch MP; Pan Q
J Viral Hepat; 2016 Apr; 23(4):294-304. PubMed ID: 26620360
[TBL] [Abstract][Full Text] [Related]
2. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
3. Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.
Wang W; Xu L; Brandsma JH; Wang Y; Hakim MS; Zhou X; Yin Y; Fuhler GM; van der Laan LJ; van der Woude CJ; Sprengers D; Metselaar HJ; Smits R; Poot RA; Peppelenbosch MP; Pan Q
Sci Rep; 2016 May; 6():25482. PubMed ID: 27150018
[TBL] [Abstract][Full Text] [Related]
4. Suppression of interferon-α signaling by hepatitis E virus.
Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
[TBL] [Abstract][Full Text] [Related]
5. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
6. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes.
Xu L; Zhou X; Wang W; Wang Y; Yin Y; Laan LJ; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
FASEB J; 2016 Oct; 30(10):3352-3367. PubMed ID: 27328944
[TBL] [Abstract][Full Text] [Related]
7. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
8. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
Todt D; François C; Anggakusuma ; Behrendt P; Engelmann M; Knegendorf L; Vieyres G; Wedemeyer H; Hartmann R; Pietschmann T; Duverlie G; Steinmann E
Antimicrob Agents Chemother; 2016 Apr; 60(4):2132-9. PubMed ID: 26787701
[TBL] [Abstract][Full Text] [Related]
10. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
Haldipur B; Bhukya PL; Arankalle V; Lole K
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
[TBL] [Abstract][Full Text] [Related]
11. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
12. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
13. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication.
Wang W; Wang Y; Debing Y; Zhou X; Yin Y; Xu L; Herrera Carrillo E; Brandsma JH; Poot RA; Berkhout B; Neyts J; Peppelenbosch MP; Pan Q
Antiviral Res; 2017 Apr; 140():1-12. PubMed ID: 28077314
[TBL] [Abstract][Full Text] [Related]
14. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner.
Sooryanarain H; Heffron CL; Meng XJ
mBio; 2020 Jan; 11(1):. PubMed ID: 31937650
[TBL] [Abstract][Full Text] [Related]
15. Effects of hepatitis E virus infection on interferon production
Wang M; Huang Y; He M; Peng WJ; Tian DY
World J Gastroenterol; 2018 May; 24(20):2173-2180. PubMed ID: 29853735
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis E virus persists in the presence of a type III interferon response.
Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z
PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073
[TBL] [Abstract][Full Text] [Related]
17. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
Mukherjee A; Di Bisceglie AM; Ray RB
J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
[TBL] [Abstract][Full Text] [Related]
20. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]